IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NAMRAH ZAKARIA SIDDIQ

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1144682501
CMS profile
7223676
Location
NEW HAVEN, CT

General Payments · PY2021–2024

$2,475.03

  • Reported across 96 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,668.74

72 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Hematology & Oncology CT All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,568.75 71
Education $99.99 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $289.00 13
Daiichi Sankyo Inc. $266.24 8
NOVARTIS PHARMACEUTICALS CORPORATION $109.30 5
DAVOL INC. $104.12 3
Janssen Biotech, Inc. $96.31 5
Lilly USA, LLC $95.94 4
Merck Sharp & Dohme Corporation $85.18 4
SOBI, INC $72.57 3
E.R. Squibb & Sons, L.L.C. $65.31 3
EISAI INC. $63.21 3
Takeda Pharmaceuticals U.S.A., Inc. $58.53 3
Celgene Corporation $58.34 3
GENZYME CORPORATION $52.87 2
Gilead Sciences, Inc. $48.34 3
Regeneron Healthcare Solutions, Inc. $44.83 2
Adaptive Biotechnologies Corporation $24.71 1
Astellas Pharma US Inc $21.71 1
Stemline Therapeutics Inc. $19.37 1
ARRAY BIOPHARMA INC $19.34 1
GlaxoSmithKline, LLC. $19.29 1
Pharmacosmos Therapeutics Inc. $19.11 1
EMD Serono, Inc. $18.10 1
Agios Pharmaceuticals, Inc. $17.02 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $338.92 4
PY2023 $467.37 20
PY2024 $1,668.74 72

Payment records · PY2024 (72)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20212023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Adaptive Biotechnologies Corporation $24.71 05/08/2024 Food and Beverage Undisputed 01/23/2026 1150262226 CMS
Agios Pharmaceuticals, Inc. $17.02 10/25/2024 Food and Beverage Undisputed 01/23/2026 1149643412 CMS
ARRAY BIOPHARMA INC $19.34 02/08/2024 Food and Beverage Undisputed 01/23/2026 1131733732 CMS
Astellas Pharma US Inc $21.71 04/17/2024 Food and Beverage Undisputed 01/23/2026 1139412887 CMS
AstraZeneca Pharmaceuticals LP $29.08 01/09/2024 Food and Beverage Undisputed 01/23/2026 1105494309 CMS
AstraZeneca Pharmaceuticals LP $23.10 01/22/2024 Food and Beverage Undisputed 01/23/2026 1105734495 CMS
AstraZeneca Pharmaceuticals LP $24.81 01/25/2024 Food and Beverage Undisputed 01/23/2026 1104616074 CMS
AstraZeneca Pharmaceuticals LP $0.18 01/25/2024 Food and Beverage Undisputed 01/23/2026 1105707752 CMS
AstraZeneca Pharmaceuticals LP $18.76 02/12/2024 Food and Beverage Undisputed 01/23/2026 1105548707 CMS
AstraZeneca Pharmaceuticals LP $30.87 04/22/2024 Food and Beverage Undisputed 01/23/2026 1105258567 CMS
AstraZeneca Pharmaceuticals LP $21.14 04/26/2024 Food and Beverage Undisputed 01/23/2026 1105215412 CMS
AstraZeneca Pharmaceuticals LP $15.32 07/01/2024 Food and Beverage Undisputed 01/23/2026 1105347222 CMS
AstraZeneca Pharmaceuticals LP $27.72 07/12/2024 Food and Beverage Undisputed 01/23/2026 1105889457 CMS
AstraZeneca Pharmaceuticals LP $26.41 11/08/2024 Food and Beverage Undisputed 01/23/2026 1105710266 CMS
AstraZeneca Pharmaceuticals LP $18.72 11/20/2024 Food and Beverage Undisputed 01/23/2026 1104446217 CMS
AstraZeneca Pharmaceuticals LP $30.74 11/27/2024 Food and Beverage Undisputed 01/23/2026 1104430321 CMS
AstraZeneca Pharmaceuticals LP $22.15 12/16/2024 Food and Beverage Undisputed 01/23/2026 1105285315 CMS
Celgene Corporation $17.06 05/03/2024 Food and Beverage Undisputed 01/23/2026 1101092029 CMS
Celgene Corporation $20.10 10/24/2024 Food and Beverage Undisputed 01/23/2026 1101092033 CMS
Celgene Corporation $21.18 12/20/2024 Food and Beverage Undisputed 01/23/2026 1101092035 CMS
Daiichi Sankyo Inc. $24.58 01/10/2024 Food and Beverage Undisputed 01/23/2026 1089482917 CMS
Daiichi Sankyo Inc. $18.04 05/09/2024 Food and Beverage Undisputed 01/23/2026 1089482921 CMS
Daiichi Sankyo Inc. $27.23 05/20/2024 Food and Beverage Undisputed 01/23/2026 1089482919 CMS
Daiichi Sankyo Inc. $20.50 05/24/2024 Food and Beverage Undisputed 01/23/2026 1089482923 CMS
Daiichi Sankyo Inc. $99.99 08/23/2024 Education Undisputed 01/23/2026 1089482913 CMS
Daiichi Sankyo Inc. $19.98 08/23/2024 Food and Beverage Undisputed 01/23/2026 1089482925 CMS
Daiichi Sankyo Inc. $29.46 10/07/2024 Food and Beverage Undisputed 01/23/2026 1089482911 CMS
Daiichi Sankyo Inc. $26.46 12/04/2024 Food and Beverage Undisputed 01/23/2026 1089482915 CMS
Davol Inc. $15.88 02/01/2024 Food and Beverage Undisputed 01/23/2026 1127665356 CMS
Davol Inc. $14.12 02/01/2024 Food and Beverage Undisputed 01/23/2026 1127665358 CMS
Davol Inc. $74.12 02/01/2024 Food and Beverage Undisputed 01/23/2026 1127665360 CMS
E.R. Squibb & Sons, L.L.C. $23.80 02/22/2024 Food and Beverage Undisputed 01/23/2026 1101257637 CMS
E.R. Squibb & Sons, L.L.C. $20.27 05/06/2024 Food and Beverage Undisputed 01/23/2026 1101257649 CMS
E.R. Squibb & Sons, L.L.C. $21.24 09/13/2024 Food and Beverage Undisputed 01/23/2026 1101257669 CMS
Eisai Inc. $19.00 04/15/2024 Food and Beverage Undisputed 01/23/2026 1110769013 CMS
Eisai Inc. $18.22 10/04/2024 Food and Beverage Undisputed 01/23/2026 1110769015 CMS
Eisai Inc. $25.99 12/23/2024 Food and Beverage Undisputed 01/23/2026 1110769017 CMS
EMD Serono, Inc. $18.10 04/25/2024 Food and Beverage Undisputed 01/23/2026 1120228564 CMS
GENZYME CORPORATION $29.48 04/25/2024 Food and Beverage Undisputed 01/23/2026 1139672111 CMS
GENZYME CORPORATION $23.39 11/15/2024 Food and Beverage Undisputed 01/23/2026 1139672197 CMS
Gilead Sciences, Inc. $14.26 02/01/2024 Food and Beverage Undisputed 01/23/2026 1133802608 CMS
Gilead Sciences, Inc. $16.94 07/15/2024 Food and Beverage Undisputed 01/23/2026 1133802610 CMS
Gilead Sciences, Inc. $17.14 09/23/2024 Food and Beverage Undisputed 01/23/2026 1133802612 CMS
GlaxoSmithKline, LLC. $19.29 11/25/2024 Food and Beverage Undisputed 01/23/2026 1116366324 CMS
Janssen Biotech, Inc. $15.76 01/16/2024 Food and Beverage Undisputed 01/23/2026 1078380950 CMS
Janssen Biotech, Inc. $25.49 03/01/2024 Food and Beverage Undisputed 01/23/2026 1078380685 CMS
Janssen Biotech, Inc. $18.93 05/29/2024 Food and Beverage Undisputed 01/23/2026 1078380814 CMS
Janssen Biotech, Inc. $18.16 08/31/2024 Food and Beverage Undisputed 01/23/2026 1078381276 CMS
Janssen Biotech, Inc. $17.97 10/23/2024 Food and Beverage Undisputed 01/23/2026 1078380846 CMS
Lilly USA, LLC $24.12 02/23/2024 Food and Beverage Undisputed 01/23/2026 1135233460 CMS
Lilly USA, LLC $23.74 04/19/2024 Food and Beverage Undisputed 01/23/2026 1135263662 CMS
Lilly USA, LLC $26.53 07/22/2024 Food and Beverage Undisputed 01/23/2026 1135175447 CMS
Lilly USA, LLC $21.55 10/11/2024 Food and Beverage Undisputed 01/23/2026 1135267984 CMS
Merck Sharp & Dohme LLC $20.56 06/28/2024 Food and Beverage Undisputed 01/23/2026 1141740353 CMS
Merck Sharp & Dohme LLC $18.85 08/19/2024 Food and Beverage Undisputed 01/23/2026 1141740523 CMS
Merck Sharp & Dohme LLC $23.41 09/27/2024 Food and Beverage Undisputed 01/23/2026 1141880743 CMS
Merck Sharp & Dohme LLC $22.36 11/04/2024 Food and Beverage Undisputed 01/23/2026 1141740537 CMS
Novartis Pharmaceuticals Corporation $19.44 03/08/2024 Food and Beverage Undisputed 01/23/2026 1087321617 CMS
Novartis Pharmaceuticals Corporation $19.93 04/29/2024 Food and Beverage Undisputed 01/23/2026 1087321621 CMS
Novartis Pharmaceuticals Corporation $20.58 05/15/2024 Food and Beverage Undisputed 01/23/2026 1087321623 CMS
Novartis Pharmaceuticals Corporation $27.49 10/31/2024 Food and Beverage Undisputed 01/23/2026 1087321627 CMS
Novartis Pharmaceuticals Corporation $21.86 11/11/2024 Food and Beverage Undisputed 01/23/2026 1087321629 CMS
Pharmacosmos Therapeutics Inc. $19.11 06/05/2024 Food and Beverage Undisputed 01/23/2026 1154826149 CMS
Regeneron Healthcare Solutions, Inc. $25.75 07/05/2024 Food and Beverage Undisputed 01/23/2026 1114171655 CMS
Regeneron Healthcare Solutions, Inc. $19.08 08/02/2024 Food and Beverage Undisputed 01/23/2026 1114171658 CMS
SOBI, INC $24.53 03/04/2024 Food and Beverage Undisputed 01/23/2026 1141430929 CMS
SOBI, INC $24.02 06/03/2024 Food and Beverage Undisputed 01/23/2026 1141430933 CMS
SOBI, INC $24.02 10/21/2024 Food and Beverage Undisputed 01/23/2026 1141430973 CMS
Stemline Therapeutics Inc. $19.37 04/26/2024 Food and Beverage Undisputed 01/23/2026 1142962527 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.56 01/19/2024 Food and Beverage Undisputed 01/23/2026 1137675817 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.14 05/13/2024 Food and Beverage Undisputed 01/23/2026 1137675819 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.83 08/09/2024 Food and Beverage Undisputed 01/23/2026 1137675821 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.